Literature DB >> 20614200

A lifetime of dedication to the old in his Kentucky home.

Mark P Mattson1.   

Abstract

He spent tens of thousands of hours peering through the oculars of a microscope at stained brain tissue sections from thousands of patients who died with or without a neurodegenerative disorder; most of those patients he had himself cared for and had removed and processed their brain tissues upon their death. His discerning mind, humble demeanor, optimism and patience were fundamental features of his character. Through his research discoveries and advocacy, Dr. William R. Markesbery fought for those millions of elderly Americans with Alzheimer's disease (AD) and their families and friends. For over a decade, my laboratory was located directly above Dr. Markesbery's in the Sanders-Brown Research Center on Aging at the University of Kentucky in Lexington. In this article, I first provide several examples of how he moved research on AD forward on multiple fronts, not only by building one of the best AD Research Centers in the world, but also by providing a helping hand to the tens of thousands of Kentuckian's and their families to ease their suffering as best he could. Also described below are the results of several research projects on which I had the good fortune of collaborating with Dr. Markesbery.

Entities:  

Mesh:

Year:  2010        PMID: 20614200     DOI: 10.1007/s12017-010-8124-8

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   3.843


  14 in total

1.  4-Hydroxynonenal, a product of lipid peroxidation, damages cholinergic neurons and impairs visuospatial memory in rats.

Authors:  A J Bruce-Keller; Y J Li; M A Lovell; P J Kraemer; D S Gary; R R Brown; W R Markesbery; M P Mattson
Journal:  J Neuropathol Exp Neurol       Date:  1998-03       Impact factor: 3.685

2.  Laser microprobe analysis of brain aluminum in Alzheimer's disease.

Authors:  M A Lovell; W D Ehmann; W R Markesbery
Journal:  Ann Neurol       Date:  1993-01       Impact factor: 10.422

3.  Autoantibodies to amyloid beta-peptide (Abeta) are increased in Alzheimer's disease patients and Abeta antibodies can enhance Abeta neurotoxicity: implications for disease pathogenesis and vaccine development.

Authors:  Avindra Nath; Elizabeth Hall; Marnia Tuzova; Michael Dobbs; Melina Jons; Caroline Anderson; Jerold Woodward; Zhihong Guo; Weiming Fu; Richard Kryscio; David Wekstein; Charles Smith; William R Markesbery; Mark P Mattson
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

4.  Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation.

Authors:  R J Mark; Z Pang; J W Geddes; K Uchida; M P Mattson
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

5.  A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide.

Authors:  R J Mark; M A Lovell; W R Markesbery; K Uchida; M P Mattson
Journal:  J Neurochem       Date:  1997-01       Impact factor: 5.372

6.  Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease.

Authors:  M A Lovell; W D Ehmann; M P Mattson; W R Markesbery
Journal:  Neurobiol Aging       Date:  1997 Sep-Oct       Impact factor: 4.673

7.  Comparison of the effects of elevated intracellular aluminum and calcium levels on neuronal survival and tau immunoreactivity.

Authors:  M P Mattson; M A Lovell; W D Ehmann; W R Markesbery
Journal:  Brain Res       Date:  1993-01-29       Impact factor: 3.252

8.  Evidence that gamma-secretase mediates oxidative stress-induced beta-secretase expression in Alzheimer's disease.

Authors:  Dong-Gyu Jo; Thiruma V Arumugam; Ha-Na Woo; Jong-Sung Park; Sung-Chun Tang; Mohamed Mughal; Dong-Hoon Hyun; Jun-Hyung Park; Yun-Hyung Choi; A-Ryeong Gwon; Simonetta Camandola; Aiwu Cheng; Huaibin Cai; Weihong Song; William R Markesbery; Mark P Mattson
Journal:  Neurobiol Aging       Date:  2008-08-08       Impact factor: 4.673

Review 9.  Immunotherapy for Alzheimer's disease: will vaccination work?

Authors:  Jean-Cosme Dodart; Kelly R Bales; Steven M Paul
Journal:  Trends Mol Med       Date:  2003-03       Impact factor: 11.951

10.  Defective DNA base excision repair in brain from individuals with Alzheimer's disease and amnestic mild cognitive impairment.

Authors:  Lior Weissman; Dong-Gyu Jo; Martin M Sørensen; Nadja C de Souza-Pinto; William R Markesbery; Mark P Mattson; Vilhelm A Bohr
Journal:  Nucleic Acids Res       Date:  2007-08-17       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.